MDTClinical Trials•prnewswire•September 4, 2025 at 04:15 PM

Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints

Sentiment:Positive (80)

Summary

(NYSE:MDT) First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting GALWAY, Ireland and NASHVILLE, Tenn., Sept. 4, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced results from the...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on September 4, 2025 by prnewswire